Dr Matthew Anstey
MBBS MPH FACEM FCICM PGDipEcho DCH Choosing Wisely Australia Advisory Board Member Medical Advisor to Australian Commission on Safety and Quality in Health Care Intensive Care Physician Sir Charles Gairdner Hospital August 2015
Dr Matthew Anstey MBBS MPH FACEM FCICM PGDipEcho DCH Choosing - - PowerPoint PPT Presentation
Dr Matthew Anstey MBBS MPH FACEM FCICM PGDipEcho DCH Choosing Wisely Australia Advisory Board Member Medical Advisor to Australian Commission on Safety and Quality in Health Care Intensive Care Physician Sir Charles Gairdner Hospital August
MBBS MPH FACEM FCICM PGDipEcho DCH Choosing Wisely Australia Advisory Board Member Medical Advisor to Australian Commission on Safety and Quality in Health Care Intensive Care Physician Sir Charles Gairdner Hospital August 2015
*reference available on request
9
HT/lipids therapy without assessing risk, don’t self monitor type 2 DM oral, don’t screen low risk CV patients, avoid BDZ with history misuse/multiple agents.
& hyperlipidaemia < 7yrs of life, Vitamin D, tumour markers
lower spine & cervical spine; duplex ultrasound, PE
Immunology and Allergy
13
Sydney Morning Herald